Dimension Inx announces the addition of biotech industry leaders Paul K. Wotton, Ph.D., as Board Director and Chris Ehrlich as Senior Advisor
Dr. Wotton fills the role of Independent Director of the Board, created following Dimension's Series A raise of $15M completed in February 2023.
- Dr. Wotton fills the role of Independent Director of the Board, created following Dimension's Series A raise of $15M completed in February 2023.
- He brings an expert perspective on platform growth opportunities as a leader of multiple global biotechnology and pharmaceutical companies.
- Dr. Wotton is a serial entrepreneur and inventor with experience spanning scientific research, product development, and transformational business transactions.
- Chris Ehrlich joins the company as Senior Advisor focusing on corporate development and financial strategy.